Corcept Therapeutics
CORT
Last Price
52 Week Range
$28.66 - $117.33
Next Earnings Date
May 04 2026 (Estimate)
Next Earnings Date
May 04 2026 (Est.)
Last Price
Corcept Therapeutics SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Corcept Therapeutics Incorporated | 8-K | March 25, 2026 | |
Corcept Therapeutics Incorporated | 8-K | February 24, 2026 | |
Corcept Therapeutics Incorporated | 10-K | February 24, 2026 | |
Corcept Therapeutics Incorporated | 8-K | February 19, 2026 | |
Corcept Therapeutics Incorporated | 8-K | January 22, 2026 | |
Corcept Therapeutics Incorporated | 8-K | December 31, 2025 | |
Corcept Therapeutics Incorporated | 10-Q | November 4, 2025 | |
Corcept Therapeutics Incorporated | 8-K | November 4, 2025 | |
Corcept Therapeutics Incorporated | 8-K | October 14, 2025 | |
Corcept Therapeutics Incorporated | 8-K | October 6, 2025 | |
Corcept Therapeutics Incorporated | 8-K | September 10, 2025 | |
Corcept Therapeutics Incorporated | 8-K | July 31, 2025 | |
Corcept Therapeutics Incorporated | 10-Q | July 31, 2025 | |
Corcept Therapeutics Incorporated | 8-K | July 14, 2025 | |
Corcept Therapeutics Incorporated | 8-K | June 16, 2025 | |
Corcept Therapeutics Incorporated | 10-Q | May 5, 2025 | |
Corcept Therapeutics Incorporated | 8-K | May 5, 2025 | |
Corcept Therapeutics Incorporated | DEF 14A | April 25, 2025 | |
Corcept Therapeutics Incorporated | 8-K | March 31, 2025 | |
Corcept Therapeutics Incorporated | 8-K | March 3, 2025 | |
Corcept Therapeutics Incorporated | 8-K | February 26, 2025 | |
Corcept Therapeutics Incorporated | 10-K | February 26, 2025 | |
Corcept Therapeutics Incorporated | 8-K | December 30, 2024 | |
Corcept Therapeutics Incorporated | 10-Q | October 30, 2024 | |
Corcept Therapeutics Incorporated | 8-K | October 30, 2024 | |
Corcept Therapeutics Incorporated | 8-K | July 29, 2024 | |
Corcept Therapeutics Incorporated | 10-Q | July 29, 2024 | |
Corcept Therapeutics Incorporated | 8-K | May 23, 2024 | |
Corcept Therapeutics Incorporated | 8-K | May 1, 2024 | |
Corcept Therapeutics Incorporated | 10-Q | May 1, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.